The Resilience of Early-stage European Healthtech

Since 2020, the European healthtech landscape has changed almost beyond recognition. Demand for cutting-edge solutions has transcended the individual to touch the level of health systems, insurers and employers. The enterprise value of European healthtech start-ups has surged, outstripping Asia and the US, and Europe has emerged as a key, global player.

Video and full report here: https://octopusventures.com/reports/the-resilience-of-early-stage-european-healthtech/

In The Resilience of Early-Stage European Healthtech we set out to explore the continent’s rapidly changing healthtech ecosystem. We’ve called on industry leaders, from founders and investors to clinicians, to offer a comprehensive analysis of an evolving sector.

Read the report for: 

• A deep dive into the European healthtech investment landscape, with a special focus on three key territories: the UK, France and Germany. 

• Our analysis of the emergent trends set to change the face of healthcare, including consumer trends and pioneering new technologies. 

• The go-to-market strategies we’ve seen used most effectively by founders, alongside our analysis of when to use them.

• A guide to the regulatory challenges founders face. 

• Our predictions for the trends and technologies poised to make the biggest impact in 2023 and 2024.